Berus Tomasz, Halon Agnieszka, Markiewicz Anna, Orlowska-Heitzman Jolanta, Romanowska-Dixon Bozena, Donizy Piotr
The Clinical Ward of Ophthalmology, Fourth Military Clinical Hospital with Polyclinic, Wroclaw, Poland
Department of Pathomorphology and Oncological Cytology, Wroclaw Medical University, Wroclaw, Poland.
Anticancer Res. 2017 Dec;37(12):6541-6549. doi: 10.21873/anticanres.12110.
Uveal melanoma is the most prevalent primary intraocular cancer in adults. Although it accounts for only 5% of all melanomas, it is responsible for 13% of deaths due to this type of cancer. A wide variety of therapeutic options of primary tumor is available and progress in its management is noticeable. The fact still remains, however, that almost half of patients develop metastases which may be due to practically undetectable cancer spread present as early as at diagnosis of the primary focus. Metastatic disease is uniformly fatal despite systemic therapy. Prediction of metastasis is crucial for prognosis. It also allows targeting of emerging new therapeutic methods to the appropriate group of patients. The Authors reviewed literature concerning epidemiology and etiopathogenesis of uveal melanoma, and its clinical, histopathological and cytogenetic prognosticators.
葡萄膜黑色素瘤是成人中最常见的原发性眼内癌。尽管它仅占所有黑色素瘤的5%,但却导致了13%的此类癌症死亡。原发性肿瘤有多种治疗选择,其治疗进展显著。然而,事实仍然是,几乎一半的患者会发生转移,这可能是由于早在原发性病灶诊断时就存在几乎无法检测到的癌症扩散。尽管进行了全身治疗,转移性疾病仍然是致命的。转移的预测对预后至关重要。它还允许将新出现的治疗方法针对合适的患者群体。作者回顾了有关葡萄膜黑色素瘤的流行病学、病因发病机制及其临床、组织病理学和细胞遗传学预后指标的文献。